Delivery Order SPE2DB24D2205-SPE2DB25FEELG
Award Date
7/2/25
Potential Completion Date
7/3/25
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 SYRINGE 0.5ML. The $9,692.02 firm-fixed-price contract has a completion date of June 10, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which enables the company to supply a wide range of pharmaceutical products and...
This is a $10,536.49 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of GARDASIL 9 SYRINGE 0.5ML. The contract has an ultimate completion date of June 27, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of GARDASIL 9 SYRINGE 0.5ML. The contract has a firm fixed price, with a ceiling value of $13,152.10, and an ultimate completion date of May 30, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, and has a ceiling value of $26,152.42. The contract is a Firm Fixed Price type and runs through March 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,411.39 firm fixed-price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of July 3, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, which serves as a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 SYRINGE 0.5ML. The contract has a firm fixed price of $4,027.12 and a completion date of June 11, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 SYRINGE 0.5ML. The contract has a firm fixed price, with a ceiling value of $3,390.54, and a period of performance through June 27, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a ceiling value of $9,995.66. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a ceiling value of $6,475.40 and a performance period ending on July 3, 2025. The contract has a firm fixed-price pricing type and is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of GARDASIL 9 syringes. The contract has a ceiling value of $6,286.35 and a completion date of May 21, 2025. It is a firm-fixed price contract without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA...